Login
$XENE
$35.77 +$0.43 (1.22%) Close

Ownership

13F as of Q2 2026 · 96.8M shares outstanding

Who owns XENE?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 46.0%
FMR LLC 10.0% · BlackRock, Inc. 7.8%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
311
+22 vs last qtr
Net shares bought
+713.0K
by institutions in Q2 2026
New / sold out
48 / 26
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Jupiter Topco LLC NEW +4.2M
  • Price T Rowe Associates Inc /MD/ +1.9M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −4.2M
  • Wellington Management Group LLP −3.4M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$22M
15 notices from 7 people
Shares covered
381.6K
0.39% of the company
Arranged in advance
97%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$8.9M$17.8MNov 2025: $4.4K under a 10b5-1 planNovDec 2025: $1.1M under a 10b5-1 planDecJan 2026: $1.8M under a 10b5-1 planJanFebMar 2026: $17.8M under a 10b5-1 planMarAprMayJun 2026: $133.1K under a 10b5-1 planJunJulAug 2026: $437.7K under a 10b5-1 planAug 2026: $640.6K without a planAugSepOct
Largest proposed sellers
  • Ian Mortimer Officer 10b5-1 $20.3M
  • Steven Gannon Director $641K

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2015–FY2025
+454.9%
+20.97% a year
Each share's claim on the business
−82.0%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $184M
over 10 fiscal years
Diluted shares, split-adjusted
13.9M46.9M80.0M2015: 14.3M shares'152016: 15.5M shares'162017: 18.0M shares'172018: 19.4M shares'182020: 34.5M shares'202021: 43.6M shares'212022: 60.5M shares'222023: 66.9M shares'232024: 77.9M shares'242025: 79.3M shares'25
Buybacks Stock-based comp
$0$26.9M$53.7M2015 buybacks: $02015 stock comp: $3.7M'152016 buybacks: $02016 stock comp: $2.2M'162017 buybacks: $02017 stock comp: $2.2M'172018 buybacks: $02018 stock comp: $2.6M'182020 buybacks: $02020 stock comp: $5.7M'202021 buybacks: $02021 stock comp: $10.0M'212022 buybacks: $02022 stock comp: $20.4M'222023 buybacks: $02023 stock comp: $32.4M'232024 buybacks: $02024 stock comp: $50.7M'242025 buybacks: $02025 stock comp: $53.7M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years47% 3–5 years15% 1–3 years20% Under 1 year18%
Quarterly turnover
19.7%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting XENE on Form 13F
F
FMR LLC
Shares
9.6M
% of company
9.96%
Change vs last qtr
−1.2M (−10.8%)
Held since
≤2021
B
BlackRock, Inc.
Shares
7.5M
% of company
7.77%
Change vs last qtr
+1.9M (+33.4%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Xenon Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting XENE on Form N-PORT; together they hold 43.4% of the company
SW
SMALLCAP World Fund Inc
Position value
$189M
% of company
3.23%
% of the fund
0.20%
As of
June 30, 2026
SA
Fidelity Rutland Square Trust II
Position value
$164M
% of company
2.81%
% of the fund
0.06%
As of
August 31, 2026

23 more funds behind a free account

See every fund holding Xenon Pharmaceuticals Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
MI
Mortimer Ian
Insider
Shares
82.8K
% of company
0.09%
Change vs last qtr
—
Held since
—
PG
Patou Gary
Insider
Shares
34.8K
% of company
0.04%
Change vs last qtr
—
Held since
—

9 more holders behind a free account

See every insider and 5%+ holder of Xenon Pharmaceuticals Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support